Catriona Yale
CIK 1779308 · Chief Development Officer · last filed 2025-12-09
Catriona Yale is a Chief Development Officer who has filed 52 SEC Form 4 insider transactions across 1 company since 2019. The most recent filing, for AKRO, was dated Dec 9, 2025. Across all open-market trades the lifetime net is −$17.9M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
52
-$17.93M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Akero Therapeutics, Inc. (AKRO) Delisted | Chief Development Officer | 0 | $54.65 | $0 | -$17.93M | 52 | 2025-12-09 |
Recent Filings
52 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-09 | Akero Therapeutics, Inc. (AKRO) Delisted | Disp (D) | −74,800 | $0 | EDGAR |
| 2025-11-06 | Akero Therapeutics, Inc. (AKRO) Delisted | Exer (M) | +8,266 | $200.0K | EDGAR |
| 2025-09-12 | Akero Therapeutics, Inc. (AKRO) Delisted | Sell (S) | −659 | -$28.4K | EDGAR |
| 2025-07-18 | Akero Therapeutics, Inc. (AKRO) Delisted | Mixed | — | -$330.8K | EDGAR |
| 2025-07-02 | Akero Therapeutics, Inc. (AKRO) Delisted | Grant (A) | +890 | $21.2K | EDGAR |
| 2025-06-20 | Akero Therapeutics, Inc. (AKRO) Delisted | Mixed | — | -$331.3K | EDGAR |
| 2025-06-20 | Akero Therapeutics, Inc. (AKRO) Delisted | Sell (S) | −1,633 | -$89.6K | EDGAR |
| 2025-06-12 | Akero Therapeutics, Inc. (AKRO) Delisted | Sell (S) | −2,803 | -$151.4K | EDGAR |
| 2025-05-19 | Akero Therapeutics, Inc. (AKRO) Delisted | Mixed | — | -$182.0K | EDGAR |
| 2025-04-16 | Akero Therapeutics, Inc. (AKRO) Delisted | Mixed | — | -$152.5K | EDGAR |